James R. Tobin - 09 Nov 2026 Form 4 Insider Report for TransMedics Group, Inc. (TMDX)

SEC form
4
Accepted by SEC
12 Nov 2026, 16:15:03 UTC
Prior SEC filing
16 Sep 2026
Next SEC filing
12 Nov 2026
Source filing
View source filing
Filing notes and source

Key filing fact

James R. Tobin filed Form 4 for TransMedics Group, Inc. (TMDX) on 12 Nov 2026.

Key facts

  • This page summarizes James R. Tobin's Form 4 filing for TransMedics Group, Inc. (TMDX).
  • 2 reported transactions and 0 derivative rows are listed below.
  • Accepted by SEC: 12 Nov 2026, 16:15.

Change

  • Previous filing in this sequence was filed on 16 Sep 2026.
  • Current net transaction value: -$385,464.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001190128 Primary reporting owner

TOBIN JAMES R

Relationship
Director

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

TMDX transaction

Common Stock

Sale

Transaction value
-$5,544
Shares
-59
Change %
-0.85%
Price
$93.96
Shares after
6,922
Date
09 Nov 2026
Ownership
Direct
TMDX transaction

Common Stock

Sale

Transaction value
-$379,920
Shares
-4,000
Change %
-58%
Price
$94.98
Shares after
2,922
Date
09 Nov 2026
Ownership
Direct
Footnotes
F1
TMDX holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
155,146
Date
09 Nov 2026
Ownership
By the James R. Tobin 2012 Trust
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $94.98 to $95.01, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .